Published online before print April 10, 2008

This Article Full Text (Rapid PDF) Supplemental Material All Versions of this Article: jmoldx.2008.070153v1 10/3/203    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doleshal, M. Articles by Szafranska, A. E. Search for Related Content PubMed PubMed Citation Articles by Doleshal, M. Articles by Szafranska, A. E.

Copyright © 2008 American Society for Investigative Pathology
Journal of Molecular Diagnostics, doi:10.2353/jmoldx.2008.070153

Accepted for publication December 28, 2007.

Technical Advance

Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues

From Asuragen, Inc., Austin, Texas

^@ To whom correspondence should be addressed. E-mail: aszafranska{at}asuragen.com.

	Abstract

Histopathology archives of well-annotated formalin-fixed, paraffin-embedded (FFPE) tissue specimens are valuable resources for retrospective studies of human diseases. Since recovery of quality intact mRNA compatible with molecular techniques is often difficult due to degradation, we evaluated microRNA (miRNA), a novel class of small RNA molecules with growing therapeutic and diagnostic potential, as an alternative analyte for gene expression studies of FFPE samples. Analyzing total RNA yield, miRNA recovery, and robustness of real-time polymerase chain reaction for miRNA, mRNA, and rRNA species, we compared the performance of commercially available RNA isolation kits and identified a preferred methodology. We further implemented modifications to increase tissue throughput and incorporate a quantitative Armored RNA process control to monitor RNA recovery efficiency. The optimized process was tested for reproducibility as well as interoperator and interday variability, and was validated with a set of 30 clinical samples. In addition, we demonstrated that, independent of FFPE block age and RNA quality, miRNAs generate quantitative reverse transcription-polymerase chain reaction signals that are more robust and better correlate with expression levels from frozen reference samples compared with longer mRNAs. Our broad study, including a total of 272 independent RNA isolations from 17 tissue types and 65 FFPE blocks up to 12 years old, indicates that miRNAs are not only suitable but are also likely superior analytes for the molecular characterization of compromised archived clinical specimens.

This article has been cited by other articles:

				S. T. Glenn, K. L. Head, B. T. Teh, K. W. Gross, and H. L. Kim Maximizing RNA Yield from Archival Renal Tumors and Optimizing Gene Expression Analysis J Biomol Screen, January 1, 2010; 15(1): 80 - 85. [Abstract] [Full Text] [PDF]

				N. K. Cervigne, P. P. Reis, J. Machado, B. Sadikovic, G. Bradley, N. N. Galloni, M. Pintilie, I. Jurisica, B. Perez-Ordonez, R. Gilbert, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma Hum. Mol. Genet., December 15, 2009; 18(24): 4818 - 4829. [Abstract] [Full Text] [PDF]

				A. Junker, M. Krumbholz, S. Eisele, H. Mohan, F. Augstein, R. Bittner, H. Lassmann, H. Wekerle, R. Hohlfeld, and E. Meinl Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 Brain, December 1, 2009; (2009) awp300v1. [Abstract] [Full Text] [PDF]

				Z. Ma, W.-O. Lui, A. Fire, and S. S. Dadras Profiling and Discovery of Novel miRNAs from Formalin-Fixed, Paraffin-Embedded Melanoma and Nodal Specimens J. Mol. Diagn., September 1, 2009; 11(5): 420 - 429. [Abstract] [Full Text] [PDF]

				J. Zhang, D. D. Jima, C. Jacobs, R. Fischer, E. Gottwein, G. Huang, P. L. Lugar, A. S. Lagoo, D. A. Rizzieri, D. R. Friedman, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation Blood, May 7, 2009; 113(19): 4586 - 4594. [Abstract] [Full Text] [PDF]

				J. B. Overdevest, D. Theodorescu, and J. K. Lee Utilizing the Molecular Gateway: The Path to Personalized Cancer Management Clin. Chem., April 1, 2009; 55(4): 684 - 697. [Abstract] [Full Text] [PDF]

				A. E. Szafranska, M. Doleshal, H. S. Edmunds, S. Gordon, J. Luttges, J. B. Munding, R. J. Barth Jr, E. J. Gutmann, A. A. Suriawinata, J. Marc Pipas, et al. Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues Clin. Chem., October 1, 2008; 54(10): 1716 - 1724. [Abstract] [Full Text] [PDF]

				W. Tam The Emergent Role of MicroRNAs in Molecular Diagnostics of Cancer J. Mol. Diagn., September 1, 2008; 10(5): 411 - 414. [Abstract] [Full Text] [PDF]